Ignyta, Inc. - Product Pipeline Review - 2016 - Global Markets Direct - Market Research

Ignyta, Inc. - Product Pipeline Review - 2016

Ignyta, Inc. - Product Pipeline Review - 2016 - Global Markets Direct - Market Research
Ignyta, Inc. - Product Pipeline Review - 2016
Published Jun 08, 2016
38 pages — Published Jun 08, 2016
Price US$ 1,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Ignyta, Inc. - Product Pipeline Review - 2016, provides an overview of the Ignyta, Inc.s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Ignyta, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Ignyta, Inc.
- The report provides overview of Ignyta, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Ignyta, Inc.s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Ignyta, Inc.s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Ignyta, Inc.s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Ignyta, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Ignyta, Inc.s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  
Source:
Document ID
GMDHC08063CDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables41
  List of Figures41
Ignyta, Inc. Snapshot51
  Ignyta, Inc. Overview51
  Key Information51
  Key Facts51
Ignyta, Inc. Research and Development Overview63
  Key Therapeutic Areas63
Ignyta, Inc. Pipeline Review92
  Pipeline Products by Stage of Development91
  Pipeline Products Monotherapy101
Ignyta, Inc. Pipeline Products Glance113
  Ignyta, Inc. Clinical Stage Pipeline Products111
    Phase II Products/Combination Treatment Modalities111
    Phase I Products/Combination Treatment Modalities121
  Ignyta, Inc. Early Stage Pipeline Products131
    Preclinical Products/Combination Treatment Modalities131
Ignyta, Inc. Drug Profiles148
  entrectinib141
    Product Description141
    Mechanism of Action141
    R&D Progress142
  RXDX-105161
    Product Description161
    Mechanism of Action161
    R&D Progress161
  taladegib171
    Product Description171
    Mechanism of Action171
    R&D Progress172
  RXDX-106191
    Product Description191
    Mechanism of Action191
    R&D Progress192
  Small Molecules to Inhibit Protein kinase C-iota for Cancer211
    Product Description211
    Mechanism of Action211
    R&D Progress211
Ignyta, Inc. Pipeline Analysis226
  Ignyta, Inc. Pipeline Products by Target222
  Ignyta, Inc. Pipeline Products by Route of Administration241
  Ignyta, Inc. Pipeline Products by Molecule Type251
  Ignyta, Inc. Pipeline Products by Mechanism of Action262
Ignyta, Inc. Recent Pipeline Updates285
Ignyta, Inc. Dormant Projects331
Ignyta, Inc. Discontinued Pipeline Products342
  Discontinued Pipeline Product Profiles341
    RXDX-103341
    RXDX-104341
    RXDX-107341
    RXDX-108341
    Small Molecule 1 for Oncology341
    Small Molecule 2 for Oncology351
    Small Molecule 3 for Oncology351
    taladegib351
Ignyta, Inc. Locations And Subsidiaries361
  Head Office361
Appendix372
  Methodology371
  Coverage371
  Secondary Research371
  Primary Research371
  Expert Panel Validation371
  Contact Us371
  Disclaimer381

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Ignyta, Inc. - Product Pipeline Review - 2016" Jun 08, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Ignyta-Inc-Product-Pipeline-Review-2016-2088-15932>
  
APA:
Global Markets Direct - Market Research. (2016). Ignyta, Inc. - Product Pipeline Review - 2016 Jun 08, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Ignyta-Inc-Product-Pipeline-Review-2016-2088-15932>
  
US$ 1,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.